You can edit almost every page by Creating an account. Otherwise, see the FAQ.

Kintor Pharmaceutical

From EverybodyWiki Bios & Wiki




Script error: No such module "Draft topics". Script error: No such module "AfC topic".


Kintor Pharmaceutical
Public
Traded as
ISIN🆔
Industry
Founded 📆2009; 15 years ago (2009) in Suzhou
Founder 👔
Headquarters 🏙️No. 20 Songbei Road,
Suzhou
,
China
Area served 🗺️
Key people
Youzhi Tong
Products 📟 Pharmaceuticals
Members
Number of employees
🌐 Websiteen.kintor.com.cn
📇 Address
📞 telephone

Kintor Pharmaceuticals is a Chinese pharmaceutical company founded in 2009 that focuses on developing novel innovative small molecules and biologic drugs for androgen-related diseases.

Its primary drug candidate is proxalutamide which is in phase III clinical trials in China for metastatic castration-resistant prostate cancer (mCRPC). The company is also developing other drug candidates, including a phase II small molecule drug candidate Pyrilutamide, a phase II monoclonal antibody drug candidate ALK-1, a phase I mTOR inhibitor drug candidate Detorsertib and an inhibitor of the hedgehog signal translation pathway GT1708F.

See also[edit]

References[edit]



This article "Kintor Pharmaceutical" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Kintor Pharmaceutical. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.